Also in patients with ARDS (18) and severe COVID-19 (19), the protein levels of ACE-S and ACE behaved differently, and higher levels of Ang I than Ang II have been reported in patients with ARDS (17) and vasodilatory shock (40) as indicators of mortality. This evidence concerns the gene AGT and COVID-19.